Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by somweyungguyon Sep 18, 2016 8:48pm
95 Views
Post# 25250376

RE:Italy Trials a success!?

RE:Italy Trials a success!?You taking notes?

The first one is free then, it's a monthly subscription.

With 1.2M shares traded for the entire year of 2008, and ALL subsequent financings "well organized", I'm HAPPY to report they do in fact, "OWN IT ALL"  Not a lot of fun when it's at 25 cents and somebody is using your slice of pie for geometry class, but eventually EDT stock on the TSX will travel "sans traffic" like a fancy new Vega509 ; - ) on the Scajaquada Expressway.

Giiddy up folks, the 176 patient decision made official only 1 YEAR ago supported an expected 20%+ absolute benefit.  Based on the known 45% composite mortality rate and the shared info of a 62% mortality expectation on SOC ( standard of care ), we have the potential to see a mid 30% "Abby Ben".  We're told that 20%+ could support a share price of $8+...I'm excited, I tired of taking all the risk with a fraction of the info.  As much fun as it's binn, it's time for something good to happen for the 5% to 10% sitting in the "greys"...the Hot Stove Lounge Boys need to show their cards before there is another round of Crown.

Warmest regards,
Squarewheel ( shareholder 1997 ) 

Bullboard Posts